BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 21466532)

  • 1. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
    Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
    Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
    Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
    Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
    Park KK; Wu JJ; Koo J
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.
    Wolf P; Hofer A; Legat FJ; Bretterklieber A; Weger W; Salmhofer W; Kerl H
    Br J Dermatol; 2009 Jan; 160(1):186-9. PubMed ID: 19067710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis.
    De Simone C; D'Agostino M; Capizzi R; Capponi A; Venier A; Caldarola G
    Eur J Dermatol; 2011; 21(4):568-72. PubMed ID: 21697032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
    Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR;
    J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis.
    Amornpinyokeit N; Asawanonda P
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):285-9. PubMed ID: 17100735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
    Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
    Ortonne JP; Khemis A; Koo JY; Choi J
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial.
    Wolf P; Weger W; Legat FJ; Posch-Fabian T; Gruber-Wackernagel A; Inzinger M; Salmhofer W; Hofer A
    Br J Dermatol; 2012 Jan; 166(1):147-53. PubMed ID: 21910714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
    Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
    Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of etanercept and phototherapy-resistant psoriasis using the excimer laser.
    Park KK; Swan J; Koo J
    Dermatol Online J; 2012 Mar; 18(3):2. PubMed ID: 22483513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
    Asawanonda P; Amornpinyokeit N; Nimnuan C
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis.
    Legat FJ; Hofer A; Wackernagel A; Salmhofer W; Quehenberger F; Kerl H; Wolf P
    Arch Dermatol; 2007 Aug; 143(8):1016-22. PubMed ID: 17709660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
    Bagel J
    J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
    Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
    Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
    Asawanonda P; Nateetongrungsak Y
    J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.